1. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis. Issue 9 (9th September 2008) Authors: Denton, C P; Engelhart, M; Tvede, N; Wilson, H; Khan, K; Shiwen, X; Carreira, P E; Gonzalez, F Diaz; Black, C M; van den Hoogen, F H Journal: Annals of the rheumatic diseases Issue: Volume 68:Issue 9(2009) Page Start: 1433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis. Issue 6746 (4th August 1990) Authors: Hansen, T M; Kryger, P; Elling, H; Haar, D; Kreutzfeldt, M; Ingeman-Nielsen, M W; Olsson, A T; Pedersen, C; Rahbek, A; Tvede, N Journal: BMJ Issue: Volume 301:Issue 6746(1990) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Issue 1 (January 1992) Authors: Brynskov, J; Tvede, N; Andersen, C B; Vilien, M Journal: Gut Issue: Volume 33:Issue 1(1992) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin. Issue 7 (July 1990) Authors: Brynskov, J; Tvede, N Journal: Gut Issue: Volume 31:Issue 7(1990) Page Start: 795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗